Compare Amgen, Inc. (AMGN) vs Heron Therapeutics Inc (HRTX) Price & Performance

Amgen, Inc.Trade

Heron Therapeutics IncTrade

Price performance (Past 24H)

Key statistics

Amgen, Inc. vs Heron Therapeutics Inc — how do they compare? Amgen, Inc. trades at $412.21 (market cap $224.14B), while Heron Therapeutics Inc trades at $0.32 (market cap $61.47M). The key difference: Amgen, Inc. is far larger — about 3646.3× Heron Therapeutics Inc's market cap, and Amgen, Inc. pays a 2.43% dividend while Heron Therapeutics Inc pays none. Which is the better fit depends on your goals.

	AMGN	HRTX
Market Cap	$224.14B	$61.47M
Sector	Health	Health
52-Week High	$417.20	$1.49
52-Week Low	$271.18	$0.32
Enterprise Value	$267.45B	$168.21M
Dividend Yield	2.43%	—

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

AMGN

BioCryst hits profitability with strong Q2 revenue, sparking takeover interest in rare disease biotech.24/7 Wall Street · 1 day agoBullish View details →

HRTX

Heron Therapeutics misses Q2 earnings and revenue estimates, pauses sales expansion, withdraws full-year outlook.Alex Lavoie · 1 day agoBearish View details →

About Amgen, Inc.

Amgen is a leader in biotechnology-based human therapeutics, with historical expertise in renal disease and cancer supportive-care products. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drug Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). Amgen's biosimilar portfolio includes Mvasi (biosimilar Avastin), Kanjinti (biosimilar Herceptin), and Amgevita (biosimilar Humira).

About Heron Therapeutics Inc

Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.